Working... Menu

Nilotinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01252017
Recruitment Status : Completed
First Posted : December 2, 2010
Last Update Posted : September 12, 2018
Information provided by (Responsible Party):
National Taiwan University Hospital